医疗补助扩张与非小细胞肺癌局部治疗的差异有关
Isheeta Madeka1, Shale J Mack2,3, Hamza Rshaidat4
1Division of Thoracic Surgery, Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA. ixm219@jefferson.edu.
Annals of surgical oncology
|March 5, 2025
概括
医疗补助计划的扩大可能会改善获得肺癌治疗的机会. 扩张状态的患者在局部治疗率下降较小,手术率增加,这表明医疗保健获得改善.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 公共卫生政策 公共卫生政策
背景情况:
- 负担得起的医疗保健法案的医疗补助扩张旨在改善医疗保健的获取和结果.
- 医疗补助扩展对肺癌治疗的影响,特别是局部治疗,仍然没有得到充分的研究.
研究的目的:
- 调查医疗补助扩展与接受局部治疗的早期非小细胞肺癌 (NSCLC) 之间的关联.
- 为了比较医疗补助扩张状态和扩张前和扩张后的非扩张状态中的患者之间的治疗率.
主要方法:
- 从国家癌症数据库 (2010-2019) 中对149966名临床T1-2,N0,M0NSCLC患者的回顾性分析.
- 用差异差异 (DID) 分析比较扩张状态和非扩张状态的患者.
- 作为局部疗法,对手术和立体性身体辐射疗法 (SBRT) 的比率的评估.
主要成果:
- 与非扩张状态相比,扩张状态中的局部治疗和手术率下降较小 (DID分别为1.24%和1.4%).
- 在医疗补助患者中,局部治疗和手术率在扩张状态中显著增加 (DID分别为7.8%和8.0%).
- 患者旅行距离大于10英里,在扩张状态下减少了更多.
结论:
- 医疗补助扩张与NSCLC局部治疗率的差异变化有关.
- 调查结果表明,医疗补助扩张可能会改善医疗保健的准入,用于早期NSCLC的第一线治疗.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1000
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K